相关实验视频
Updated: Jun 13, 2025

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
3.5K
在儿科中非IgE介导的药物诱导过敏反应
Timothy G Chow1, Anum F Muzaffar2, Santiago Alvarez-Arango3,4
1Division of Allergy and Immunology, Department of Pediatrics and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
Current opinion in pediatrics
|September 10, 2024
概括
儿童非IgE介导的药物诱导过敏反应 (DHRs) 尚不清楚. 最近的研究改善了这些DHR的识别,诊断和管理,影响了儿科患者的护理.
科学领域:
- 儿科过敏和免疫学
- 临床药理学 临床药理学
- 免疫皮肤学 免疫皮肤学
背景情况:
- 非免疫球蛋白E (IgE) 介导的药物诱导过敏反应 (DHRs) 在儿童中很常见,但研究不足.
- 这些反应呈现出从轻微的皮肤问题到严重的全身性疾病的范围,其机制和诊断工具尚不清楚.
- 目前的诊断局限性导致不必要的药物避开和增加医疗保健成本.
研究的目的:
- 审查近期在儿童群体中理解非IgE介导的DHR的进展.
- 突出需要进一步研究的领域,以改善临床识别,诊断和管理.
- 加强对儿童这些反应的识别和治疗策略.
主要方法:
- 文献综述侧重于最近的研究和非IgE介导的DHR的进展.
- 分析有关病理生理机制和诊断标记的新发现.
- 对临床表现和管理策略的当前知识的综合.
主要成果:
- 更好地了解即时和延迟的非IgE介导药物反应.
- 鉴定与Mas相关的G蛋白结合受体X2和与严重皮肤不良反应相关的HLA基因.
- 有前途的诊断技术,如皮肤测试和生物标志物的探索反应严重程度.
结论:
- 非IgE介导的DHR显著增加了儿科的发病率,需要改变治疗.
- 最近的研究提供了对临床特征和机制的见解,指导了更好的诊断和治疗方法.
- 改进的策略对于优化儿科DHR患者的治疗结果至关重要.
相关概念视频
Allergic Drug Reactions
821
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
821
Allergic Reactions
27.3K
Overview
27.3K
Hypersensitivities
556
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
556
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
246
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
246
Drugs Used in Lower Respiratory Disorders: Overview
362
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
362
Upper Respiratory Drugs: First and Second-Generation Antihistamines
223
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
223

